News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
878,114 Results
Type
Article (88471)
Company Profile (813)
Press Release (788800)
Multimedia
Podcasts (223)
Webinars (34)
Section
Business (233454)
Career Advice (4156)
Deals (39932)
Drug Delivery (170)
Drug Development (91581)
Employer Resources (207)
FDA (18494)
Job Trends (17462)
News (398411)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3042)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (179)
Alliances (56986)
ALS (213)
Alzheimer's disease (1903)
Antibody-drug conjugate (ADC) (473)
Approvals (18756)
Artificial intelligence (771)
Autoimmune disease (274)
Automation (57)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (230)
Biotechnology (486)
Bladder cancer (192)
Brain cancer (78)
Breast cancer (750)
Cancer (5936)
Cardiovascular disease (515)
Career advice (3586)
Career pathing (48)
CAR-T (342)
CDC (73)
Celiac Disease (2)
Cell therapy (942)
Cervical cancer (46)
Clinical research (78126)
Collaboration (2190)
Company closure (7)
Compensation (1362)
Complete response letters (97)
COVID-19 (3021)
CRISPR (112)
C-suite (1123)
Cystic fibrosis (161)
Data (7620)
Decentralized trials (3)
Denatured (83)
Depression (181)
Dermatology (72)
Diabetes (606)
Diagnostics (7462)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (383)
Drug pricing (239)
Drug shortages (39)
Duchenne muscular dystrophy (289)
Earnings (101479)
Editorial (74)
Employer branding (25)
Employer resources (174)
Events (136980)
Executive appointments (1132)
FDA (22209)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1793)
Gene editing (243)
Generative AI (85)
Gene therapy (773)
GLP-1 (1224)
Government (5525)
Grass and pollen (8)
Guidances (406)
Healthcare (21062)
HIV (85)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (334)
Immuno-oncology (97)
Indications (167)
Infectious disease (3388)
Inflammatory bowel disease (227)
Inflation Reduction Act (17)
Influenza (145)
Intellectual property (289)
Interviews (818)
IPO (17982)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (21)
Labor market (107)
Layoffs (673)
Leadership (47)
Legal (10169)
Liver cancer (106)
Longevity (32)
Lung cancer (792)
Lymphoma (427)
Machine learning (59)
Management (66)
Manufacturing (1068)
MASH (196)
Medical device (15180)
Medtech (15269)
Mergers & acquisitions (23163)
Metabolic disorders (1628)
mRNA (231)
Multiple sclerosis (190)
NASH (24)
Neurodegenerative disease (445)
Neuropsychiatric disorders (120)
Neuroscience (3486)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (794)
Opinion (363)
Ovarian cancer (210)
Pain (263)
Pancreatic cancer (288)
Parkinson's disease (377)
Partnered (39)
Patents (598)
Patient recruitment (655)
Peanut (66)
People (67568)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24143)
Phase 2 (33922)
Phase 3 (25516)
Pipeline (7835)
Policy (378)
Postmarket research (3556)
Preclinical (10860)
Press Release (72)
Prostate cancer (300)
Psychedelics (64)
Radiopharmaceuticals (344)
Rare diseases (1144)
Real estate (7449)
Recruiting (81)
Regulatory (29855)
Reports (75)
Research institute (2761)
Resumes & cover letters (653)
Rett syndrome (35)
RNA editing (25)
RSV (98)
Schizophrenia (183)
Series A (299)
Series B (220)
Service/supplier (30)
Sickle cell disease (117)
Special edition (30)
Spinal muscular atrophy (186)
Sponsored (53)
Startups (4353)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (137)
Vaccines (1248)
Venture capital (115)
Weight loss (546)
Women's health (123)
Worklife (24)
Date
Today (164)
Last 7 days (799)
Last 30 days (2948)
Last 365 days (33254)
2026 (10446)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58723)
2020 (57665)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1294)
Alabama (100)
Alaska (7)
Arizona (379)
Arkansas (16)
Asia (51977)
Australia (9136)
California (13153)
Canada (3737)
China (1391)
Colorado (568)
Connecticut (582)
Delaware (400)
Europe (119700)
Florida (1952)
Georgia (429)
Hawaii (4)
Idaho (69)
Illinois (1127)
India (95)
Indiana (618)
Iowa (25)
Japan (530)
Kansas (138)
Kentucky (53)
Louisiana (45)
Maine (87)
Maryland (1613)
Massachusetts (9612)
Michigan (397)
Minnesota (741)
Mississippi (7)
Missouri (159)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (92)
New Jersey (3527)
New Mexico (33)
New York (3474)
North Carolina (1790)
North Dakota (10)
Northern California (6445)
Ohio (406)
Oklahoma (26)
Oregon (55)
Pennsylvania (2627)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (85)
South Dakota (2)
Southern California (5130)
Tennessee (210)
Texas (2121)
United States (47274)
Utah (394)
Vermont (1)
Virginia (334)
Washington D.C. (88)
Washington State (1087)
West Virginia (4)
Wisconsin (147)
Wyoming (2)
There are 878,114 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Humacyte Appoints Jim Mercadante as Chief Commercial Officer
April 22, 2026
·
8 min read
Press Releases
Neurona Presents Updated Data from Ongoing Clinical Trials of Rezanecel (NRTX-1001) Regenerative Cell Therapy in Mesial Temporal Lobe Epilepsy at 2026 American Academy of Neurology (AAN) Annual Meeting
April 22, 2026
·
6 min read
Press Releases
Cloudbreak Pharma Announces Presentation on its Multi-Kinase Inhibition (MKI) Platform and Ongoing Clinical Programs at Eyecelerator @ ARVO 2026
April 22, 2026
·
8 min read
Press Releases
MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29
April 22, 2026
·
1 min read
Press Releases
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
April 22, 2026
·
6 min read
Press Releases
PMV Pharmaceuticals Announces Board Chair Transition
April 22, 2026
·
6 min read
Press Releases
Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026
April 22, 2026
·
1 min read
Manufacturing
FDA issues warning letter after GLP-1 manufacturer refuses inspectors access
New Life told FDA inspectors that they lacked the authority to enter parts of a facility where it made the GLP-1 receptor agonists semaglutide and tirzepatide.
April 22, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
NeuroDex and Stanford Researchers Publish First Evidence of CNS Target Engagement for GLP-1 and PPARγ Agonists Using Blood-Based Neuron-Derived Extracellular Vesicles
New study in the Journal of Clinical Endocrinology & Metabolism demonstrates that NeuroDex’s ExoSORT platform can detect central Akt–mTOR signaling changes in response to metabolic drugs — from a routine blood draw.
April 22, 2026
·
1 min read
Psychedelics
Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients
With a greenlight for ibogaine to enter clinical testing and three unnamed products set to receive Commissioner’s National Priority Vouchers this week, it’s full speed ahead for psychedelics. But will sidestepping normal regulatory protocols actually be a net negative for the field?
April 22, 2026
·
8 min read
·
Heather McKenzie
1 of 87,812
Next
